Advertisement

Rhokinase Inhibitors for Endothelial Decompensation

  • Dhivya Ashok Kumar
Chapter

Abstract

Cornea is a unique structure with varied physiological mechanism working for its transparency and integrity. Orientation of collagen, arrangements of keratocytes, fluid transport mechanism, endothelial cell function and proteoglycan proportions are some of the factors which contribute to its physical nature. Conditions which hinder the above normal systematic functions are known to affect corneal transparency. Corneal endothelial cell is one vital structure which is highly efficient in preserving the vitality of the corneal layers.

Keywords

Corneal Endothelium Corneal Endothelial Cell Rock Inhibitor Corneal Dystrophy Human Corneal Endothelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Wulle KG. Electron microscopy of the fetal development of the corneal endothelium and Descemet’s membrane of the human eye. Invest Ophthalmol. 1972;11:897–904.Google Scholar
  2. 2.
    Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science. 1995;269:1270–2.CrossRefPubMedGoogle Scholar
  3. 3.
    Olson MF. Applications for ROCK kinase inhibition. Curr Opin Cell Biol. 2008;20:242–8.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Narumiya S, Ishizaki T, Uehata M. Use and properties of ROCK-specific inhibitor Y-27632. Methods Enzymol. 2000;325:273–84.CrossRefPubMedGoogle Scholar
  5. 5.
    Okumura N, Ueno M, Koizumi N, Sakamoto Y, Hirata K, et al. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci. 2009;50:3680–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Okumura N, Nakano S, Kay EP, et al. Involvement of cyclin D and p27 in cell proliferation mediated by ROCK inhibitors Y-27632 and Y-39983 during corneal endothelium wound healing. Invest Ophthalmol Vis Sci. 2014;55:318–29.CrossRefPubMedGoogle Scholar
  7. 7.
    Yoshizaki H, Ohba Y, Parrini MC, et al. Cell type-specific regulation of RhoA activity during cytokinesis. J Biol Chem. 2004;279:44756–62.CrossRefPubMedGoogle Scholar
  8. 8.
    Coleman ML, Olson MF. Rho GTPase signalling pathways in the morphological changes associated with apoptosis. Cell Death Differ. 2002;9:493–504.CrossRefPubMedGoogle Scholar
  9. 9.
    Liao JK, Seto M, Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol. 2007;50:17–24.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Pipparelli A, Arsenijevic Y, Thuret G, Gain P, Nicolas M, Majo F. ROCK inhibitor enhances adhesion and wound healing of human corneal endothelial cells. PLoS One. 2013;8(4):e62095.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Okumura N, Koizumi N, Ueno M, Sakamoto Y, Takahashi H, Hamuro J, Kinoshita S. The new therapeutic concept of using a rho kinase inhibitor for the treatment of cornealendothelial dysfunction. Cornea. 2011;30 Suppl 1:S54–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Okumura N, Kinoshita S, Koizumi N. Cell-based approach for treatment of corneal endothelial dysfunction. Cornea. 2014;33 Suppl 11:S37–41.CrossRefPubMedGoogle Scholar
  13. 13.
    Koizumi N, Okumura N, Ueno M, Nakagawa H, Hamuro J, Kinoshita S. Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy. Cornea. 2013;32(8):1167–70.CrossRefPubMedGoogle Scholar
  14. 14.
    Okumura N, Koizumi N, Kay EP, Ueno M, Sakamoto Y, Nakamura S, Hamuro J, Kinoshita S. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. Invest Ophthalmol Vis Sci. 2013;54(4):2493–502.CrossRefPubMedGoogle Scholar
  15. 15.
    Okumura N, Koizumi N, Ueno M, et al. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. Am J Pathol. 2012;181:268–77.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Dr. Agarwal’s Refractive and Cornea FoundationDr. Agarwal’s Eye Hospital and Eye Research CentreChennaiIndia

Personalised recommendations